> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Committee to Discuss Hypogonadism Drug Trial Designs
- URL: https://www.fdaweb.com/committee-to-discuss-hypogonadism-drug-trial-designs/
- Published: 2016-09-23T12:00:00.000Z
- Updated: 2026-09-14T21:34:36.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5136900

*Federal Register* Notice: FDA has announced a 12/6 meeting of its Bone, Reproductive and Urologic Drugs Advisory Committee. The committee will discuss appropriate clinical trial design features, including acceptable endpoints for demonstrating clinical benefit, for drugs intended to treat secondary hypogonadism while preserving or improving testicular function, including spermatogenesis. To view this notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2016-09-23/pdf/2016-22925.pdf?ref=fdaweb.com).